Viridian Therapeutics, Inc. Common Stock (VRDN)

Viridian Therapeutics (VRDN) stock shows mixed signals with a 52-week high but recent price dips and declining social engagement. Analyst sentiment remains positive following a public offering and regulatory milestones.

About Viridian Therapeutics, Inc. Common Stock

Viridian Therapeutics, Inc. is a biotechnology company focused on therapies for thyroid eye disease.
Viridian Therapeutics, Inc. Common Stock uses the ticker $VRDN for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Viridian Therapeutics, Inc. Common Stock (VRDN) social dominance is up 577.78% from the previous week.
Viridian Therapeutics, Inc. Common Stock (VRDN) engagements is up 121.8% from the previous [--] months.

Price: $27.90

Price 24-Hour Time-Series Raw Data
The stock has reached a 52-week high, supported by positive analyst sentiment and a successful public offering, despite a recent 24-hour dip and declining social media engagement.

24-Hour: -3.02% 7-Day: -5.74% 30-Day: -16.12%

1-Year High: $33.80 on 2026-01-14
1-Year Low: $11 on 2025-04-08

AltRank: [-----]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Viridian Therapeutics, Inc. Common Stock (VRDN) is currently AltRank #1,114 based on combined combined social and market metrics Daily Average: [-----]
[--] Week: [---] [----]
[--] Month: [-----] +129
[--] Months: [-----] +456
[--] Year: [-----] +641
1-Year High: [-----] on 2026-01-26
1-Year Low: [--] on 2025-11-23

Galaxy Score: [--]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] +5
1-Year High: [--] on 2025-12-22
1-Year Low: [--] on 2025-12-02

Engagements: [-----] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Week: [------] +82%
[--] Month: [-------] +39%
[--] Months: [-------] +57%
[--] Year: [---------] -48%
1-Year High: [------] on 2025-12-14
1-Year Low: [--] on 2025-04-21

Engagements by network (24h): X: [-----] TikTok: [--] News: [--] Reddit: [--] YouTube: [--]

Mentions: [--] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +4.90%
[--] Month: [---] +82%
[--] Months: [-----] -16%
[--] Year: [-----] +70%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-10-11

Mentions by network (24h): X: [--] TikTok: [--] News: [--] Reddit: [--] YouTube: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Viridian Therapeutics, Inc. Common Stock (VRDN) in the last [--] hours which is down 28% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [--] -4.70%
[--] Month: [---] +76%
[--] Months: [---] -51%
[--] Year: [-----] +161%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-10-11

The most influential creators that mention Viridian Therapeutics, Inc. Common Stock in the last [--] hours

Creator	Rank	Followers	Posts	Engagements
@BiopharmIQ	[--]	[------]	[--]	[-----]
@Andre_AGTC	[--]	[-----]	[--]	[---]
@stockmktgenius	[--]	[------]	[--]	[--]
@Angelinafrazier	[--]		[--]	[--]
@SteveDJacobs	[--]	[------]	[--]	[--]
@StockConsultant	[--]	[-----]	[--]	[--]

Sentiment: 75%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 75%
Daily Average: 87%
[--] Week: 100% no change
[--] Month: 77% +7%
[--] Months: 77% -23%
[--] Year: 77% -23%
1-Year High: 100% on 2025-02-17
1-Year Low: 14% on 2025-09-22

Most Supportive Themes:

Analyst Upgrades and Price Targets: (40%) Financial analysts have increased their price targets for Viridian Therapeutics, indicating positive sentiment from the financial community.
Public Offering and Financial Health: (30%) The company's recent public offering has strengthened its financial position, providing resources for future development.
Regulatory Milestones: (20%) The submission of a Biologics License Application (BLA) to the FDA for veligrotug is a significant step towards potential market approval.

Most Critical Themes:

Declining Social Media Engagement: (15%) Despite positive company news, social media interest is decreasing, with notable drops in engagement and mentions.

Social Dominance: 0.00392%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00392%
Daily Average: 0.00511%
[--] Week: 0.018% +0.016%
[--] Month: 0.0048% +0.0006999999999999992%
[--] Months: 0.0048% -0.0013%
[--] Year: 0.0048% -0.0034%
1-Year High: 0.033% on 2025-06-29
1-Year Low: 0.0005% on 2025-10-11

Market Dominance: 0.00302%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00302%
Daily Average: 0%
1-Year High: 0.129% on 2026-02-06
1-Year Low: 0.00302% on 2026-02-16

Market Cap: $2,662,832,023

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $2,662,832,023
Daily Average: $2,996,580,131
[--] Week: $2,643,743,622 -6.40%
[--] Month: $2,662,832,023 -16%
1-Year High: $3,224,031,030 on 2026-01-14
1-Year Low: $2,662,832,023 on 2026-02-13

Top Viridian Therapeutics, Inc. Common Stock Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"#Deeptrack Feb 13'26 Massive $XBI put 22% of portfolio Vary bearish move👀 Changed position of interest $XBI put New #1 $IMVT +19% #2 $AXSM +28% #7 $CYTK -22% #6 $VRDN -53% #19"
X Link @Andre_AGTC 2026-02-14T18:26Z [----] followers, [----] engagements

"Each quarter we identify major catalyst events 🚨 Likely to move the stock +/- by 20% $NKTR Rezpegaldesleukin (NKTR-358) Ph2b $RGNX RGX-202 Ph2/3 $VRDN Veligrotug (formerly VRDN-001) PDUFA Access our FREE Big Mover Report below 👇 https://www.offers.bpiq.com/big-mover-lpmo=jun https://www.offers.bpiq.com/big-mover-lpmo=jun"
X Link @BiopharmIQ 2026-02-14T16:03Z 28.9K followers, [----] engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q1 [----] 📈 $MDNAF Phase 2b $GOSS Phase [--] $BFRI Phase [--] $MLTX Phase [--] $BFRI Phase [--] $BCDA Phase [--] $KPTI Phase [--] $IOVA Phase [--] $XENE Phase [--] $AGIO Phase 2b $AVBP Phase [--] $ATAI Phase [--] $MLYS Phase [--] $TARA Phase [--] $CADL Phase 2a $ANRO Phase [--] $IMMP Phase [--] $PEPG Phase [--] $TBPH Phase [--] $CLDX Phase [--] $NVCR Phase [--] $VRDN Phase [--] $CMPX Phase 2/3 $ZBIO Phase [--] $IDYA Phase 2/3 $VXRT Phase 2b $OCUL Phase [--] $LSTA Phase 2b $PCSA Phase [--] $OCGN Phase [--] $APGE Phase [--] $CMPS Phase [--] $MBRX Phase [--] $KOD Phase [--] $NKTR Phase 2b $ALZN Phase [--] $HELP Phase [--] $PVLA"
X Link @BiopharmIQ 2026-02-08T18:59Z 28.9K followers, 21.6K engagements

"End of [----] update Top 10+15 $MDGL NASH $KRYS DEB $AXSM MDD ADA $XENE FOS $RVMD RASmuti $PRAX ET $ABVX IBD $BBIO ATTR $MIRM IBAT $CTYK oHCM $CRNX $SRRK $NKTR $NUVL $VKTX $IMVT $VTYX $CYBN $ABEO $BLTE $CPRX $ALNY $MLYS $VRDN $KYMR Q4 Update top 10+10 $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $MIRM IBAT rare $RVMD RASmuti $CRNX endocrine $BBIO ATTR $SRRK TGFb $ALNY RNAi $CPRX $ABEO $CORT $KYMR $NUVL $QURE $IMCR $NBIX $VKTX $MLYS Q4 Update top 10+10 $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $MIRM IBAT rare $RVMD RASmuti $CRNX endocrine $BBIO ATTR $SRRK TGFb $ALNY"
X Link @Andre_AGTC 2025-12-31T18:48Z [----] followers, 17.5K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing